Nanotechnology Now

Our NanoNews Digest Sponsors


Heifer International

Wikipedia Affiliate Button


DHgate

Home > Press > Third Annual Meeting of American Academy of Nanomedicine Announced

Abstract:
he American Academy of Nanomedicine (AANM) has announced that its third annual meeting will be held from September 7 to September 9, 2007 at the University of California San Diego in San Diego, USA.

Third Annual Meeting of American Academy of Nanomedicine Announced

SAN DIEGO, CA | Posted on July 23rd, 2007

Some of this years meetings categories are:
- Biomaterial and Dendrimertic Nanomedicine Biosensor and Molecular Imaging Nanomedicine
- Clinical Nanomedicine
- Commercialization and IP in Nanomedicine
- Drug Delivery Nanomedicine
- Oncology Nanomedicine
- Toxicology in Nanomedicine
- Successful Translational Nanomedicine: from Branch to Bedside

The 2-day meeting will feature keynote and plenary presentations by experts in the field, a poster session along with oral presentations of selected posters, and a roundtable discussion of the clinical prospects of nanomedicine.

AANM is a professional, academic and medical society dedicated to advancing research in Nanomedicine. Its members are experts in the fields of nanotechnology, engineering, biochemistry, molecular biology and medicine. The goals of the Academy include providing a forum for scientific investigation, communicating new findings and encouraging collaboration among the diverse disciplines represented in Nanomedicine.

More information on AANM, meeting registration, and membership submission can be found at:

http://www.aananomed.org/

####

About AANM
The American Academy of Nanomedicine is a forum to exchange ideas, communicate new findings, and encourage collaboration among the diverse disciplines represented in Nanomedicine. Among other things, membership in AANM will provide you with:

* Access to the latest information in research and clinical applications through the society’s quarterly, peer-reviewed journal, Nanomedicine: Nanotechnology, Biology, and Medicine.
* The ability to discuss challenges and innovative findings with peers, face-to-face at AANM conferences, focused specifically on Nanomedicine-related topics and issues.

For more information, please click here

Contacts:
P.O. Box 388, Monrovia, MD 21770, USA
Tel:301-760-3402
Fax:718-535-2884

Copyright © American Academy of Nanomedicine (AANM)

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

Nanomedicine

JPK’s NanoWizard AFM system is being used for cell studies in the Research Centre for Nanometer-scale Science & Advanced Materials at the Jagiellonian University in Krakow, Poland May 31st, 2016

Nanobiotix receives US$1m milestone payment from PharmaEngine: First patient injected with NBTXR3 in soft tissue sarcoma registration phase in Asia May 31st, 2016

Nanobiotix establishes promising preclinical proof-of-concept in Immuno Oncology May 31st, 2016

Automating DNA origami opens door to many new uses: Like 3-D printing did for larger objects, method makes it easy to build nanoparticles out of DNA May 30th, 2016

Announcements

JPK’s NanoWizard AFM system is being used for cell studies in the Research Centre for Nanometer-scale Science & Advanced Materials at the Jagiellonian University in Krakow, Poland May 31st, 2016

Nanobiotix receives US$1m milestone payment from PharmaEngine: First patient injected with NBTXR3 in soft tissue sarcoma registration phase in Asia May 31st, 2016

GLOBALFOUNDRIES to Expand Presence in China with 300mm Fab in Chongqing: Company plans new manufacturing facility and additional design capabilities to serve customers in China May 31st, 2016

Nanobiotix establishes promising preclinical proof-of-concept in Immuno Oncology May 31st, 2016

Events/Classes

Novel gene therapy shows potential for lung repair in asthma May 18th, 2016

Arrowhead Pharmaceuticals' Preclinical Candidate ARC-LPA Achieves 98% Knockdown and Long Duration of Effect after Subcutaneous Administration May 10th, 2016

Nanometrics Announces Upcoming Investor Events May 10th, 2016

Oxford Instruments Asylum Research and McGill University Announce the McGill AFM Summer School and Workshop, May 12-13, 2016 May 4th, 2016

NanoNews-Digest
The latest news from around the world, FREE




  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project







Car Brands
Buy website traffic